↓ Skip to main content

2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial

Overview of attention for article published in BMC Infectious Diseases, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial
Published in
BMC Infectious Diseases, August 2022
DOI 10.1186/s12879-022-07642-6
Pubmed ID
Authors

Anant Narayan Bhatt, Srinivas Shenoy, Sagar Munjal, Vijayakumar Chinnadurai, Apurva Agarwal, A. Vinoth Kumar, A. Shanavas, Ratnesh Kanwar, Sudhir Chandna

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 13%
Unspecified 2 7%
Professor 2 7%
Lecturer 1 3%
Student > Bachelor 1 3%
Other 4 13%
Unknown 16 53%
Readers by discipline Count As %
Unspecified 2 7%
Medicine and Dentistry 2 7%
Environmental Science 1 3%
Business, Management and Accounting 1 3%
Nursing and Health Professions 1 3%
Other 6 20%
Unknown 17 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2023.
All research outputs
#2,785,513
of 25,551,063 outputs
Outputs from BMC Infectious Diseases
#882
of 8,653 outputs
Outputs of similar age
#58,095
of 433,057 outputs
Outputs of similar age from BMC Infectious Diseases
#20
of 138 outputs
Altmetric has tracked 25,551,063 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,653 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,057 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 138 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.